Annual Shareholders Equity
$7.21 M
-$76.97 M-91.44%
December 31, 2023
Summary
- As of March 6, 2025, ELDN annual stockholders equity is $7.21 million, with the most recent change of -$76.97 million (-91.44%) on December 31, 2023.
- During the last 3 years, ELDN annual shareholders equity has fallen by -$183.39 million (-96.22%).
- ELDN annual shareholders equity is now -96.22% below its all-time high of $190.60 million, reached on December 31, 2020.
Performance
ELDN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$76.06 M
+$84.56 M+994.69%
September 30, 2024
Summary
- As of March 6, 2025, ELDN quarterly stockholders equity is $76.06 million, with the most recent change of +$84.56 million (+994.69%) on September 30, 2024.
- Over the past year, ELDN quarterly shareholders equity has dropped by -$15.28 million (-16.73%).
- ELDN quarterly shareholders equity is now -60.09% below its all-time high of $190.60 million, reached on December 31, 2020.
Performance
ELDN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELDN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.4% | -16.7% |
| 3 y3 years | -96.2% | -16.7% |
| 5 y5 years | -50.3% | -16.7% |
ELDN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.6% | at low | -53.6% | +994.7% |
| 5 y | 5-year | -96.2% | at low | -60.1% | +994.7% |
| alltime | all time | -96.2% | +113.0% | -60.1% | +237.6% |
Eledon Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $76.06 M(-994.7%) |
| Jun 2024 | - | -$8.50 M(-111.4%) |
| Mar 2024 | - | $74.82 M(+938.0%) |
| Dec 2023 | $7.21 M(-91.4%) | $7.21 M(-92.1%) |
| Sep 2023 | - | $91.33 M(-8.6%) |
| Jun 2023 | - | $99.95 M(+33.6%) |
| Mar 2023 | - | $74.79 M(-11.2%) |
| Dec 2022 | $84.18 M(-48.7%) | $84.18 M(-40.3%) |
| Sep 2022 | - | $141.09 M(-5.5%) |
| Jun 2022 | - | $149.38 M(-4.4%) |
| Mar 2022 | - | $156.32 M(-4.7%) |
| Dec 2021 | $164.00 M(-14.0%) | $164.00 M(-4.0%) |
| Sep 2021 | - | $170.75 M(-4.4%) |
| Jun 2021 | - | $178.52 M(-2.9%) |
| Mar 2021 | - | $183.87 M(-3.5%) |
| Dec 2020 | $190.60 M(+1913.7%) | $190.60 M(+786.2%) |
| Sep 2020 | - | $21.51 M(+129.9%) |
| Jun 2020 | - | $9.36 M(-20.3%) |
| Mar 2020 | - | $11.74 M(+24.1%) |
| Dec 2019 | $9.46 M | $9.46 M(-29.2%) |
| Sep 2019 | - | $13.37 M(-16.6%) |
| Jun 2019 | - | $16.03 M(+61.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $9.93 M(-31.5%) |
| Dec 2018 | $14.49 M(-25.5%) | $14.49 M(-20.9%) |
| Sep 2018 | - | $18.32 M(-14.8%) |
| Jun 2018 | - | $21.51 M(-11.5%) |
| Mar 2018 | - | $24.30 M(+24.9%) |
| Dec 2017 | $19.45 M(-819.9%) | $19.45 M(-5.7%) |
| Sep 2017 | - | $20.62 M(-12.0%) |
| Jun 2017 | - | $23.44 M(+0.3%) |
| Mar 2017 | - | $23.36 M(-964.7%) |
| Dec 2016 | -$2.70 M(-104.4%) | -$2.70 M(-108.9%) |
| Sep 2016 | - | $30.26 M(-22.2%) |
| Jun 2016 | - | $38.88 M(-24.4%) |
| Mar 2016 | - | $51.41 M(-16.7%) |
| Dec 2015 | $61.72 M(-40.4%) | $61.72 M(-14.2%) |
| Sep 2015 | - | $71.90 M(-13.1%) |
| Jun 2015 | - | $82.75 M(-9.0%) |
| Mar 2015 | - | $90.90 M(-12.2%) |
| Dec 2014 | $103.50 M(-287.3%) | $103.50 M(+1.9%) |
| Sep 2014 | - | $101.61 M(+415.0%) |
| Jun 2014 | - | $19.73 M(-135.7%) |
| Dec 2013 | -$55.27 M(+38.5%) | -$55.27 M |
| Dec 2012 | -$39.90 M | - |
FAQ
- What is Eledon Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual shareholders equity year-on-year change?
- What is Eledon Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Eledon Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ELDN is $7.21 M
What is the all time high annual shareholders equity for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual stockholders equity is $190.60 M
What is Eledon Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ELDN annual stockholders equity has changed by -$76.97 M (-91.44%)
What is Eledon Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ELDN is $76.06 M
What is the all time high quarterly shareholders equity for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly stockholders equity is $190.60 M
What is Eledon Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ELDN quarterly stockholders equity has changed by -$15.28 M (-16.73%)